Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TissueGene-C in Degenerative Arthritis
NCT02072070Phase 3Completed
- Sponsor
- Kolon Life Science Inc.
- Start
- Nov 2013
- Primary completion
- Aug 2015
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing TissueGene-C with Placebo (2 arms). Primary endpoints: International Knee Documentation Committee Subjective Score at Week 52 and Visual Analog Scale at Week 52. Started Nov 2013; status: completed.
02
Drugs
Invossa
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02072070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02072070.